Market Overview

Global Transfection Reagent And Equipment Market 2014-2018 & 2022 - Focus on Gene Expression, Protein Production, Cancer Research, Therapeutics -


The "Transfection
Reagent And Equipment Market Size, Share, & Trends Analysis Report By
Product, By Method, By Application (Gene Expression, Protein Production,
Cancer Research, Therapeutics), And Segment Forecasts, 2014 - 2022"

report has been added to's

The global transfection reagent & equipment market size is expected to
reach USD 1.08 billion by 2022, progressing at a CAGR of 7.4%.

The growth of the market can be attributed to ongoing oncology-based
research & development that aimed at understanding disease cause at
genomic & molecular levels coupled with consequent surging demand for
targeted therapies.

Transfection technology is recognized as an integral part of research
programs pertaining to thorough investigation of various chromosomal
anomalies. Hence, rising cancer prevalence of cancer as well as genetic
conditions is anticipated to provide a fillip to the market.
Furthermore, funds and grants by funding and government bodies are
likely to back the growth of the market.

Funding and federal agencies, such as National Science Foundation (NSF),
are offering the biotechnology sector with huge funding to carry out
their biotechnology-based investigational studies. Moreover,
international funding bodies such as NIH and Welcome Trust are projected
to play a crucial role in the growth of the market by providing funds
for genetic research studies. Such significant funds and grants are
poised to boost the adoption of transfection technology over the
forecast period.

Thermo Fisher Scientific Inc., Promega Corporation, QIAGEN, and
F.Hoffmann-La Roche Ltd are some prominent players in the market. These
companies are undertaking several endeavors to enhance their shares in
the market

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Transfection Reagents & Equipment Industry Outlook

Chapter 4 Transfection Reagents & Equipment Product Outlook

Chapter 5 Transfection Reagents & Equipment Method Outlook

Chapter 6 Transfection Reagents & Equipment Application Outlook

Chapter 7 Transfection Reagents & Equipment Regional Outlook

Chapter 8 Competitive Landscape

  • Thermo Fisher Scientific Inc
  • Promega Corporation
  • Lonza AG
  • Qiagen
  • Mirus Bio LLC
  • EMD Millipore
  • Bio-Rad Laboratories Inc.
  • OriGene Technologies Inc.
  • Merck KgaA

For more information about this report visit

View Comments and Join the Discussion!